FTSE 100
|
9 250,43
|
27,11
|
0,29 %
|
Analysen zu FTSE 100-Werten
| 30.07.25 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 30.07.25 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.07.25 | Glencore Buy | Jefferies & Company Inc. | |
| 30.07.25 | GSK Hold | Jefferies & Company Inc. | |
| 30.07.25 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 30.07.25 | Diageo Buy | Jefferies & Company Inc. | |
| 30.07.25 | Glencore Outperform | RBC Capital Markets | |
| 30.07.25 | HSBC Holdings Neutral | UBS AG | |
| 30.07.25 | GSK Neutral | UBS AG | |
| 30.07.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 30.07.25 | Rio Tinto Hold | Jefferies & Company Inc. | |
| 30.07.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | Glencore Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 30.07.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.07.25 | HSBC Holdings Buy | Jefferies & Company Inc. | |
| 30.07.25 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 29.07.25 | AstraZeneca Outperform | Bernstein Research | |
| 29.07.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 29.07.25 | Shell Outperform | RBC Capital Markets | |
| 29.07.25 | AstraZeneca Buy | UBS AG | |
| 29.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.07.25 | Diageo Outperform | Bernstein Research | |
| 28.07.25 | National Grid Buy | Jefferies & Company Inc. | |
| 28.07.25 | GSK Outperform | Bernstein Research | |
| 28.07.25 | AstraZeneca Outperform | Bernstein Research | |
| 28.07.25 | London Stock Exchange Buy | UBS AG | |
| 28.07.25 | RELX Hold | Deutsche Bank AG | |
| 28.07.25 | International Consolidated Airlines Outperform | Bernstein Research | |
| 28.07.25 | easyJet Market-Perform | Bernstein Research | |
| 25.07.25 | Rolls-Royce Buy | Deutsche Bank AG | |
| 25.07.25 | Reckitt Benckiser Equal Weight | Barclays Capital | |
| 25.07.25 | RELX Overweight | Barclays Capital | |
| 25.07.25 | RELX Buy | UBS AG | |
| 24.07.25 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 24.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.07.25 | RELX Buy | UBS AG | |
| 24.07.25 | Reckitt Benckiser Outperform | Bernstein Research | |
| 24.07.25 | Vodafone Group Underperform | Bernstein Research | |
| 24.07.25 | Vodafone Group Neutral | UBS AG |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.